AAAAAA

   
Results: 1-20 |
Results: 20
CHARACTERIZATION OF TOLERANCE DURING PROLONGED DOSING OF INTRAVENOUS RANITIDINE IN ICU-PATIENTS USING MECHANISM-BASED PHARMACOKINETIC-PHARMACODYNAMIC MODELING
Authors: MATHOT RAA VINKS AATMM LAMERS CBHW GEUS WP
Citation: Raa. Mathot et al., CHARACTERIZATION OF TOLERANCE DURING PROLONGED DOSING OF INTRAVENOUS RANITIDINE IN ICU-PATIENTS USING MECHANISM-BASED PHARMACOKINETIC-PHARMACODYNAMIC MODELING, Gastroenterology, 114(4), 1998, pp. 896-896
TIME-COURSE OF ACTION OF 3 ADENOSINE A(1) RECEPTOR AGONISTS WITH DIFFERING LIPOPHILICITY IN RATS - COMPARISON OF PHARMACOKINETIC, HEMODYNAMIC AND EEG EFFECTS
Authors: VANSCHAICK EA KULKARNI C KUNZEL JKVD MATHOT RAA CRISTALLI G IJZERMAN AP DANHOF M
Citation: Ea. Vanschaick et al., TIME-COURSE OF ACTION OF 3 ADENOSINE A(1) RECEPTOR AGONISTS WITH DIFFERING LIPOPHILICITY IN RATS - COMPARISON OF PHARMACOKINETIC, HEMODYNAMIC AND EEG EFFECTS, Naunyn-Schmiedeberg's archives of pharmacology, 356(6), 1997, pp. 827-837
8-ALKYLAMINO-SUBSTITUTED ANALOGS OF N-6-CYCLOPENTYLADENOSINE ARE PARTIAL AGONISTS FOR THE CARDIOVASCULAR ADENOSINE A(1) RECEPTORS IN-VIVO
Authors: VANSCHAICK EA MATHOT RAA GUBBENSSTIBBE JM LANGEMEIJER MWE ROELEN HCPF IJZERMAN AP DANHOF M
Citation: Ea. Vanschaick et al., 8-ALKYLAMINO-SUBSTITUTED ANALOGS OF N-6-CYCLOPENTYLADENOSINE ARE PARTIAL AGONISTS FOR THE CARDIOVASCULAR ADENOSINE A(1) RECEPTORS IN-VIVO, The Journal of pharmacology and experimental therapeutics, 283(2), 1997, pp. 800-808
MECHANISM-BASED PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF THE EFFECTS OF N-6-CYCLOPENTYLADENOSINE ANALOGS ON HEART-RATE IN RAT - ESTIMATION OF IN-VIVO OPERATIONAL AFFINITY AND EFFICACY AT ADENOSINE A(1) RECEPTORS
Authors: VANDERGRAAF PH VANSCHAICK EA MATHOT RAA IJZERMAN AP DANHOF M
Citation: Ph. Vandergraaf et al., MECHANISM-BASED PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF THE EFFECTS OF N-6-CYCLOPENTYLADENOSINE ANALOGS ON HEART-RATE IN RAT - ESTIMATION OF IN-VIVO OPERATIONAL AFFINITY AND EFFICACY AT ADENOSINE A(1) RECEPTORS, The Journal of pharmacology and experimental therapeutics, 283(2), 1997, pp. 809-816
PARTIAL AGONISM OF THE NONSELECTIVE ADENOSINE RECEPTOR AGONIST 8-BUTYLAMINOADENOSINE AT THE A(1) RECEPTOR IN-VIVO
Authors: MATHOT RAA VANDERWENDEN EM SOUDIJN W BREIMER DD IJZERMAN AP DANHOF M
Citation: Raa. Mathot et al., PARTIAL AGONISM OF THE NONSELECTIVE ADENOSINE RECEPTOR AGONIST 8-BUTYLAMINOADENOSINE AT THE A(1) RECEPTOR IN-VIVO, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1439-1446
N-6,C8-DISUBSTITUTED ADENOSINE DERIVATIVES AS PARTIAL AGONISTS FOR ADENOSINE A(1) RECEPTORS
Authors: ROELEN H VELDMAN N SPEK AL KUNZEL JVD MATHOT RAA IJZERMAN AP
Citation: H. Roelen et al., N-6,C8-DISUBSTITUTED ADENOSINE DERIVATIVES AS PARTIAL AGONISTS FOR ADENOSINE A(1) RECEPTORS, Journal of medicinal chemistry, 39(7), 1996, pp. 1463-1471
PHARMACOKINETIC-HEMODYNAMIC RELATIONSHIPS OF 2-CHLOROADENOSINE AT ADENOSINE A(1) AND A(2A) RECEPTORS IN-VIVO
Authors: MATHOT RAA SOUDIJN W BREIMER DD IJZERMAN AP DANHOF M
Citation: Raa. Mathot et al., PHARMACOKINETIC-HEMODYNAMIC RELATIONSHIPS OF 2-CHLOROADENOSINE AT ADENOSINE A(1) AND A(2A) RECEPTORS IN-VIVO, British Journal of Pharmacology, 118(2), 1996, pp. 369-377
8-SUBSTITUTED ADENOSINE AND THEOPHYLLINE-7-RIBOSIDE ANALOGS AS POTENTIAL PARTIAL AGONISTS FOR THE ADENOSINE A(1) RECEPTOR
Authors: VANDERWENDEN EM HARTOGWITTE HR ROELEN HCPF KUNZEL JKV PIROVANO IM MATHOT RAA DANHOF M VANAERSCHOT A LIDAKS MJ IJZERMAN AP SOUDIJN W
Citation: Em. Vanderwenden et al., 8-SUBSTITUTED ADENOSINE AND THEOPHYLLINE-7-RIBOSIDE ANALOGS AS POTENTIAL PARTIAL AGONISTS FOR THE ADENOSINE A(1) RECEPTOR, European journal of pharmacology. Molecular pharmacology section, 290(3), 1995, pp. 189-199
QUANTIFICATION OF THE IN-VIVO POTENCY OF THE ADENOSINE A(2) RECEPTOR ANTAGONIST 8-(3-CHLOROSTYRYL)CAFFEINE
Authors: MATHOT RAA GUBBENSSTIBBE JM SOUDIJN W JACOBSON KA IJZERMAN AP DANHOF M
Citation: Raa. Mathot et al., QUANTIFICATION OF THE IN-VIVO POTENCY OF THE ADENOSINE A(2) RECEPTOR ANTAGONIST 8-(3-CHLOROSTYRYL)CAFFEINE, The Journal of pharmacology and experimental therapeutics, 275(1), 1995, pp. 245-253
PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF THE CARDIOVASCULAR EFFECTS OF R-N-6-PHENYLISOPROPYLADENOSINE AND S-N-6-PHENYLISOPROPYLADENOSINEIN CONSCIOUS NORMOTENSIVE RATS
Authors: MATHOT RAA VANDENAARSEN BCFM SOUDIJN W BREIMER DD IJZERMAN AP DANHOF M
Citation: Raa. Mathot et al., PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF THE CARDIOVASCULAR EFFECTS OF R-N-6-PHENYLISOPROPYLADENOSINE AND S-N-6-PHENYLISOPROPYLADENOSINEIN CONSCIOUS NORMOTENSIVE RATS, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 405-414
RIBOSE-MODIFIED ADENOSINE-ANALOGS AS POTENTIAL PARTIAL AGONISTS FOR THE ADENOSINE RECEPTOR
Authors: VANDERWENDEN EM KUNZEL JKVD MATHOT RAA DANHOF M IJZERMAN AP SOUDIJN W
Citation: Em. Vanderwenden et al., RIBOSE-MODIFIED ADENOSINE-ANALOGS AS POTENTIAL PARTIAL AGONISTS FOR THE ADENOSINE RECEPTOR, Journal of medicinal chemistry, 38(20), 1995, pp. 4000-4006
DEOXYRIBOSE ANALOGS OF N-6-CYCLOPENTYLADENOSINE (CPA) - PARTIAL AGONISTS AT THE ADENOSINE A(1) RECEPTOR IN-VIVO
Authors: MATHOT RAA VANDERWENDEN EM SOUDIJN W IJZERMAN AP DANHOF M
Citation: Raa. Mathot et al., DEOXYRIBOSE ANALOGS OF N-6-CYCLOPENTYLADENOSINE (CPA) - PARTIAL AGONISTS AT THE ADENOSINE A(1) RECEPTOR IN-VIVO, British Journal of Pharmacology, 116(3), 1995, pp. 1957-1964
MODELING OF THE PHARMACODYNAMIC INTERACTION OF AN A(1) ADENOSINE RECEPTOR AGONIST AND ANTAGONIST IN-VIVO - N-6-CYCLOPENTYLADENOSINE AND 8-CYCLOPENTYLTHEOPHYLLINE
Authors: APPEL S MATHOT RAA LANGEMIJER MWE IJZERMAN AP DANHOF M
Citation: S. Appel et al., MODELING OF THE PHARMACODYNAMIC INTERACTION OF AN A(1) ADENOSINE RECEPTOR AGONIST AND ANTAGONIST IN-VIVO - N-6-CYCLOPENTYLADENOSINE AND 8-CYCLOPENTYLTHEOPHYLLINE, British Journal of Pharmacology, 115(7), 1995, pp. 1253-1259
PHARMACOKINETIC MODELING OF THE HEMODYNAMIC-EFFECTS OF THE A(2A) ADENOSINE RECEPTOR AGONIST CGS 21680C IN CONSCIOUS NORMOTENSIVE RATS
Authors: MATHOT RAA CLETON A SOUDIJN W IJZERMAN AP DANHOF M
Citation: Raa. Mathot et al., PHARMACOKINETIC MODELING OF THE HEMODYNAMIC-EFFECTS OF THE A(2A) ADENOSINE RECEPTOR AGONIST CGS 21680C IN CONSCIOUS NORMOTENSIVE RATS, British Journal of Pharmacology, 114(4), 1995, pp. 761-768
LIQUID-CHROMATOGRAPHIC DETERMINATION OF THE ADENOSINE RECEPTOR AGONIST CGS-21680 IN BLOOD USING ONLINE SOLID-PHASE EXTRACTION ON A PHENYLBORONIC ACID SUPPORT AND FLUORESCENCE DETECTION
Authors: IRTH H CLETON A MATHOT RAA DANHOF M IJZERMAN AP TJADEN UR VANDERGREEF J
Citation: H. Irth et al., LIQUID-CHROMATOGRAPHIC DETERMINATION OF THE ADENOSINE RECEPTOR AGONIST CGS-21680 IN BLOOD USING ONLINE SOLID-PHASE EXTRACTION ON A PHENYLBORONIC ACID SUPPORT AND FLUORESCENCE DETECTION, Journal of chromatography B. Biomedical applications, 658(1), 1994, pp. 207-212
PARTIAL AGONISM OF THEOPHYLLINE-7-RIBOSIDE ON ADENOSINE RECEPTORS
Authors: IJZERMAN AP VANDERWENDEN EM KUNZEL JKVD MATHOT RAA DANHOF M BOREA PA VARANI K
Citation: Ap. Ijzerman et al., PARTIAL AGONISM OF THEOPHYLLINE-7-RIBOSIDE ON ADENOSINE RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 350(6), 1994, pp. 638-645
ASSESSMENT OF THE ENANTIOMERIC PURITY OF R AND S-N-6-PHENYLISOPROPYLADENOSINE (PIA) - IMPLICATIONS FOR ADENOSINE RECEPTOR SUBCLASSIFICATION
Authors: MATHOT RAA VANDENAARSEN BCFM KUNZEL JKVD DANHOF M IJZERMAN AP
Citation: Raa. Mathot et al., ASSESSMENT OF THE ENANTIOMERIC PURITY OF R AND S-N-6-PHENYLISOPROPYLADENOSINE (PIA) - IMPLICATIONS FOR ADENOSINE RECEPTOR SUBCLASSIFICATION, Naunyn-Schmiedeberg's archives of pharmacology, 350(1), 1994, pp. 109-112
PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIP OF THE CARDIOVASCULAR EFFECTS OF ADENOSINE A(1) RECEPTOR AGONIST N-6-CYCLOPENTYLADENOSINE IN THE RAT
Authors: MATHOT RAA VANSCHAICK EA LANGEMEIJER MWE SOUDIJN W BREIMER DD IJZERMAN AP DANHOF M
Citation: Raa. Mathot et al., PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIP OF THE CARDIOVASCULAR EFFECTS OF ADENOSINE A(1) RECEPTOR AGONIST N-6-CYCLOPENTYLADENOSINE IN THE RAT, The Journal of pharmacology and experimental therapeutics, 268(2), 1994, pp. 616-624
PHARMACOKINETIC-PHARMACODYNAMIC MODELING IN PRECLINICAL INVESTIGATIONS - PRINCIPLES AND PERSPECTIVES
Authors: DANHOF M MANDEMA JW HOOGERKAMP A MATHOT RAA
Citation: M. Danhof et al., PHARMACOKINETIC-PHARMACODYNAMIC MODELING IN PRECLINICAL INVESTIGATIONS - PRINCIPLES AND PERSPECTIVES, European journal of drug metabolism and pharmacokinetics, 18(1), 1993, pp. 41-47
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF THE ADENOSINE A(1) AGONIST N-6-CYCLOPENTYLADENOSINE AND THE A(1) ANTAGONIST 8-CYCLOPENTYLTHEOPHYLLINE AND ITS APPLICATION IN A PHARMACOKINETIC STUDY IN RATS
Authors: MATHOT RAA APPEL S VANSCHAICK EA SOUDIJN W IJZERMAN AP DANHOF M
Citation: Raa. Mathot et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF THE ADENOSINE A(1) AGONIST N-6-CYCLOPENTYLADENOSINE AND THE A(1) ANTAGONIST 8-CYCLOPENTYLTHEOPHYLLINE AND ITS APPLICATION IN A PHARMACOKINETIC STUDY IN RATS, Journal of chromatography. Biomedical applications, 620(1), 1993, pp. 113-120
Risultati: 1-20 |